PT  - JOURNAL ARTICLE
AU  - Lederman, Lynne
ED  - Ravandi, Farhad
TI  - Vosaroxin in Combination With Cytarabine Provides a New Salvage Option for AML
DP  - 2014  01
TA  - MD Conference Express
PG  - 15--16
VI  - 14
IP  - 55
4099  - http://mdc.sagepub.com/content/14/55/15.short
4100  - http://mdc.sagepub.com/content/14/55/15.full
AB  - The addition of vosaroxin to cytarabine improves overall survival and complete remission rates in patients with relapsed, refractory acute myeloid leukemia. This combination is not associated with increased early mortality. Patients at least age 60 years seemed to benefit more than younger patients.